Health Canada Authorizes First GLP-1 Pill to Reduce Heart Attack and Stroke Risk
Health Canada authorizes RYBELSUS® as the first oral GLP-1 to reduce heart attack and stroke risk in adults with type 2 diabetes.
Generic Ozempic: Canada to See Significant Price Drops
Struggling with high medication costs? Generic Ozempic is coming to Canada in 2026. Learn how prices could drop from $400 to around $100.
Ozempic, Wegovy Lawsuits Raise Alarms Over Rare Vision Loss Risk
U.S. lawsuits link Ozempic and similar drugs to rare vision loss. Learn the risks of semaglutide medications and what Canadians should watch for.
Ozempic Now Approved to Treat Kidney Disease in Patients with Type 2 Diabetes
A major international study called The FLOW trial has resulted in approval for Ozempic from Health Canada to help treat CKD in people with type 2 diabetes.
A 5 lb. Gummy Bear? What’s Wrong With This Picture?
Sweet indulgence or bitter cost? Explore the rise of mega candy stores amidst a diabetes awareness crisis in our sugar-obsessed society.
Pharmacare Will Cover Contraceptives and Diabetes Care
The Pharmacare Act, Bill C-64 has officially been put into law. So what does this mean for you?
The Grapefruit Effect: A Risk You Need to Know About
Grapefruits can have a potentially lethal impact on you depending on which medications you are taking. It’s up to you to know and to stay safe. Here’s a primer to get you started.
Warning: Blood Glucose Smartwatches May Pose Serious Health Risks
Health Canada is warning that unauthorized smartwatches that claim to measure blood glucose are being sold online. They may pose serious risks to the health of people with diabetes,
Mounjaro (Tirzepatide) Now Available in Canada for Type 2 Diabetes Treatment
Mounjaro®, an injectable prescription medicine that is used to improve blood sugar (glucose) in adults with type 2 diabetes is now available in Canada.